KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Globus Medical (GMED) EBT (2016 - 2025)

Historic EBT for Globus Medical (GMED) over the last 15 years, with Q3 2025 value amounting to $144.0 million.

  • Globus Medical's EBT rose 15247.93% to $144.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $489.3 million, marking a year-over-year increase of 25622.06%. This contributed to the annual value of $149.5 million for FY2024, which is 1773.74% down from last year.
  • As of Q3 2025, Globus Medical's EBT stood at $144.0 million, which was up 15247.93% from $188.2 million recorded in Q2 2025.
  • In the past 5 years, Globus Medical's EBT ranged from a high of $188.2 million in Q2 2025 and a low of -$8.6 million during Q1 2024
  • Its 5-year average for EBT is $63.1 million, with a median of $57.0 million in 2024.
  • Examining YoY changes over the last 5 years, Globus Medical's EBT showed a top increase of 214978.3% in 2024 and a maximum decrease of 11361.0% in 2024.
  • Globus Medical's EBT (Quarter) stood at $24.2 million in 2021, then soared by 173.75% to $66.4 million in 2022, then tumbled by 37.68% to $41.4 million in 2023, then rose by 29.27% to $53.5 million in 2024, then soared by 169.35% to $144.0 million in 2025.
  • Its EBT stands at $144.0 million for Q3 2025, versus $188.2 million for Q2 2025 and $103.7 million for Q1 2025.